Metoprolol Sales Data
| Rank 77 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows metoprolol U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 77 ( 2) |
$215,111 | 2.99% | 3,097 | 4.77% |
| Q3 2013 | 79 ( 16) |
$208,861 | -12.86% | 2,956 | -0.50% |
| Q2 2013 | 63 (3) |
$239,691 | 1.44% | 2,971 | 4.10% |
| Q1 2013 | 66 (7) |
$236,279 | -1.41% | 2,854 | 16.39% |
| Q4 2012 | 59 | $239,668 | -4.04% | 2,452 | -1.25% |
| Q3 2012 | 59 (1) |
$249,769 | -0.87% | 2,483 | -2.63% |
| Q2 2012 | 58 (15) |
$251,955 | 8.89% | 2,550 | 7.78% |
| Q1 2012 | 73 | $231,395 | -0.53% | 2,366 | -6.30% |
| Q4 2011 | 73 (4) |
$232,625 | 1.20% | 2,525 | 6.27% |
| Q3 2011 | 69 (1) |
$229,868 | -4.57% | 2,376 | -5.94% |
| Q2 2011 | 68 (1) |
$240,868 | 0.96% | 2,526 | 4.38% |
| Q1 2011 | 69 | $238,586 | n/a | 2,420 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
